Resident blog - Elise Lawrence episode artwork

EPISODE · May 5, 2023 · 10 MIN

Resident blog - Elise Lawrence

from The mTOR You Know · host The mTOR You Know

On this resident blog, PGY2 SOT Elise Lawrence joins us from the University of Colorado Hospital to discuss a review of 3-year follow up data on outcomes after conversion from monthly to every 2-month belatacept maintenance therapy in low immunologic risk kidney transplant recipients, followed by a brief refresher on considerations for toxoplasmosis prophylaxis after solid organ transplant and what options to consider when patients can not utilize sulfamethoxazole-trimethoprim.

On this resident blog, PGY2 SOT Elise Lawrence joins us from the University of Colorado Hospital to discuss a review of 3-year follow up data on outcomes after conversion from monthly to every 2-month belatacept maintenance therapy in low immunologic risk kidney transplant recipients, followed by a brief refresher on considerations for toxoplasmosis prophylaxis after solid organ transplant and what options to consider when patients can not utilize sulfamethoxazole-trimethoprim.

NOW PLAYING

Resident blog - Elise Lawrence

0:00 10:52

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The mTOR You Know?

This episode is 10 minutes long.

When was this The mTOR You Know episode published?

This episode was published on May 5, 2023.

What is this episode about?

On this resident blog, PGY2 SOT Elise Lawrence joins us from the University of Colorado Hospital to discuss a review of 3-year follow up data on outcomes after conversion from monthly to every 2-month belatacept maintenance therapy in low...

Can I download this The mTOR You Know episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!